婴幼儿支气管封堵单肺通气术后不同PEEP水平对肺不张的影响

注册号:

Registration number:

ChiCTR2400084319 

最近更新日期:

Date of Last Refreshed on:

2024-05-14 16:01:35 

注册时间:

Date of Registration:

2024-05-14 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

婴幼儿支气管封堵单肺通气术后不同PEEP水平对肺不张的影响

Public title:

Effect of different PEEP levels on atelectasis after bronchial blockade one-lung ventilation in infants

注册题目简写:

English Acronym:

研究课题的正式科学名称:

婴幼儿支气管封堵单肺通气术后不同PEEP水平对肺不张的影响

Scientific title:

Effect of different PEEP levels on atelectasis after bronchial blockade one-lung ventilation in infants

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

于玲姗 

研究负责人:

于玲姗 

Applicant:

Lingshan Yu 

Study leader:

Lingshan Yu 

申请注册联系人电话:

Applicant telephone:

+86 151 5911 1656

研究负责人电话:

Study leader's
telephone:

+86 151 5911 1656

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1025814184@qq.com

研究负责人电子邮件:

Study leader's E-mail:

1025814184@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

福建省福州市晋安区横屿路966号

研究负责人通讯地址:

福建省福州市晋安区横屿路966号

Applicant address:

966 Hengyu Road, Jin 'an District, Fuzhou City, Fujian Province

Study leader's address:

966 Hengyu Road, Jin 'an District, Fuzhou City, Fujian Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

福建省儿童医院

Applicant's institution:

Fujian Children's Hospital

研究负责人所在单位:

福建省儿童医院

Affiliation of the Leader:

Fujian Children's Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2023ETKLR12010

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

福建省儿童医院伦理委员会

Name of the ethic committee:

Fujian Children's Hospital Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2023-12-08 00:00:00

伦理委员会联系人:

李晓燕

Contact Name of the ethic committee:

Xiaoyan Li

伦理委员会联系地址:

福建省福州市晋安区横屿路966号

Contact Address of the ethic committee:

966 Hengyu Road, Jin 'an District, Fuzhou City, Fujian Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 591 8611 2116

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

福建省儿童医院

Primary sponsor:

Fujian Children's Hospital

研究实施负责(组长)单位地址:

福建省福州市晋安区横屿路966号

Primary sponsor's address:

966 Hengyu Road, Jin 'an District, Fuzhou City, Fujian Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

福建省

市(区县):

福州市

Country:

China

Province:

Fujian Province

City:

Fuzhou

单位(医院):

福建省儿童医院

具体地址:

福建省福州市晋安区横屿路966号

Institution
hospital:

Fujian Children's Hospital

Address:

966 Hengyu Road, Jin 'an District, Fuzhou City, Fujian Province

经费或物资来源:

福建医科大学启航基金项目

Source(s) of funding:

Startup Fund for scientific research, Fujian Medical University

研究疾病:

肺不张  

Target disease:

atelectasis

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

拟通过前瞻性的随机对照试验分析麻醉苏醒过程使用不同PEEP联合纯氧通气在小儿支气管封堵单肺通气胸腔镜手术后对肺不张及肺损伤的影响,以确定最优的PEEP水平,从而改善患儿医疗结局质量,也为其临床应用提供依据。  

Objectives of Study:

A prospective randomized controlled trial was conducted to analyze the effects of different PEEP combined with pure oxygen ventilation on atelectasis and lung injury after one-lung ventilation thoracoscopic surgery with bronchial blockade in infants during anesthesia recovery, to determine the optimal PEEP level, so as to improve the quality of infant's medical outcomes and provide a basis for its clinical application.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

(1)气管插管内径小于3.0mm;(2)术前肺部CT或超声提示肺不张;(3)术中改为双肺通气者;(4)术中吸入氧浓度大于90%;(5)术中PEEP发生改变者;(6)呼吸、循环系统功能不全者;(7)拒绝参与研究项目者。

Exclusion criteria:

(1)The inner diameter of tracheal intubation is less than 3.0 mm; (2)Preoperative lung CT or ultrasound showed atelectasis; (3)Change to bilateral ventilation during operation;(4)The concentration of oxygen inhaled during operation is greater than 90%;(5)PEEP changes during operation;(6)Respiratory and circulatory system dysfunction;(7)Those who refuse to participate in the research project.

研究实施时间:

Study execute time:

From 2023-12-15 00:00:00 To 2025-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-06-01 00:00:00 To 2025-12-01 00:00:00

干预措施:

Interventions:

组别:

A组

样本量:

86

Group:

group A

Sample size:

干预措施:

患儿在手术结束移除支气管封堵管并复张双肺后根据需要给予PEEP 3-4cmH20,并予100%吸入氧浓度直至拔除气管插管。

干预措施代码:

Intervention:

The patients were given PEEP 3-4 cmH 20 as needed after the removal of the bronchial blockade tube and the rehabilitation of both lungs. And 100% inhaled oxygen until the endotracheal tube was removed.

Intervention code:

组别:

B组

样本量:

86

Group:

group B

Sample size:

干预措施:

患儿在手术结束移除支气管封堵管并复张双肺后根据需要给予PEEP 5-6cmH20,并予100%吸入氧浓度直至拔除气管插管。

干预措施代码:

Intervention:

The patients were given PEEP 5-6 cmH 20 as needed after the removal of the bronchial blockade tube and the rehabilitation of both lungs. And 100% inhaled oxygen until the endotracheal tube was removed.

Intervention code:

组别:

C组

样本量:

86

Group:

group C

Sample size:

干预措施:

患儿在手术结束移除支气管封堵管并复张双肺后根据需要给予PEEP 7-8cmH20,并予100%吸入氧浓度直至拔除气管插管。

干预措施代码:

Intervention:

The patients were given PEEP 7-8 cmH 20 as needed after the removal of the bronchial blockade tube and the rehabilitation of both lungs. And 100% inhaled oxygen until the endotracheal tube was removed.

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

福建省 

市(区县):

 

Country:

China

Province:

Fujian Province

City:

单位(医院):

福建省儿童医院 

单位级别:

三甲 

Institution
hospital:

Fujian Children's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术前一般情况(性别、年龄、体重)

指标类型:

次要指标

Outcome:

General preoperative condition (gender, age, body weight)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

T1(手术结束时)时间点的血流动力学指标(平均动脉血压、中心静脉压、心率)

指标类型:

次要指标

Outcome:

Hemodynamic indicators (mean arterial blood pressure, central venous pressure, heart rate)T1 (end of surgery).

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

T1(手术结束时)血气分析结果(氧和指数PaO2/FiO2、肺泡动脉氧分压差AaDO2)

指标类型:

主要指标

Outcome:

Results of blood gas analysis (oxygen and index PaO 2 / FiO 2, AaDO 2) at T1 (end of surgery)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

T1(手术结束时)血清CRP、IL-6,IL-8,IL-10,IFN-γ和 TNF-α等肺损伤炎症细胞因子含量

指标类型:

主要指标

Outcome:

Serum injury inflammatory cytokines content including CRP, IL-6, IL-8, IL-10, IFN- γ, and TNF- α at T1 (end of surgery)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

T2(拔管后1小时)时间点的血流动力学指标(平均动脉血压、中心静脉压、心率)

指标类型:

次要指标

Outcome:

Hemodynamic indicators (mean arterial blood pressure, central venous pressure, heart rate)T2 (one hour after extubation).

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

T2(拔管后1小时)血气分析结果(氧和指数PaO2/FiO2、肺泡动脉氧分压差AaDO2)

指标类型:

主要指标

Outcome:

Results of blood gas analysis (oxygen and index PaO 2 / FiO 2, AaDO 2) at T2 (one hour after extubation)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

T2(拔管后1小时)血清CRP、IL-6,IL-8,IL-10,IFN-γ和 TNF-α等肺损伤炎症细胞因子含量

指标类型:

主要指标

Outcome:

Serum injury inflammatory cytokines content including CRP, IL-6, IL-8, IL-10, IFN- γ, and TNF- α at T2 (one hour after extubation)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

T2时间点床边胸片及肺部超声肺不张评分

指标类型:

主要指标

Outcome:

T2 time point bedside chest radiograph and lung ultrasound atelectasis score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后低氧血症发生率(SPO2<90%)

指标类型:

主要指标

Outcome:

Prevalence of postoperative hypoxemia (SPO 2 <90%)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后住院天数

指标类型:

次要指标

Outcome:

Number of days in hospital after surgery

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 0.1 years
最大 Max age 1 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

研究人员对纳入研究的患儿进行编码,根据随机数生成软件生成的随机数序列进行分组,将患儿分配到3组。

Randomization Procedure (please state who generates the random number sequence and by what method):

The researchers coded the included children and grouped the random number sequence generated by the random number generation software.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

none

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

none

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Electronic Data Capture, EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2024-05-14 16:01:08